Profile data is unavailable for this security.
About the company
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
- Revenue in USD (TTM)78.07m
- Net income in USD-17.55m
- Incorporated2014
- Employees674.00
- LocationBurning Rock Biotech LtdNo. 5 Xingdao Ring Road NorthInternational Bio IslandGUANGZHOU 510005ChinaCHN
- Phone+86 18 501641666
- Websitehttps://www.brbiotech.com/
| Holder | Shares | % Held |
|---|---|---|
| Kynam Capital Management LPas of 30 Sep 2025 | 994.88k | 11.01% |
| CRCM LPas of 16 Dec 2025 | 486.43k | 5.38% |
| Amova Asset Management Americas, Inc.as of 30 Sep 2025 | 34.84k | 0.39% |
| Amova Asset Management Co., Ltd.as of 31 Dec 2025 | 31.81k | 0.35% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 31.72k | 0.35% |
| BofA Securities, Inc.as of 30 Sep 2025 | 29.16k | 0.32% |
| Prospera Financial Services, Inc.as of 30 Sep 2025 | 24.76k | 0.27% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 22.27k | 0.25% |
| Redwood Wealth Management Group LLCas of 31 Dec 2025 | 20.02k | 0.22% |
| SkyView Investment Advisors LLCas of 30 Jun 2025 | 10.00k | 0.11% |
